Alnylam Pharmaceuticals
ALNY
#523
Rank
$42.26 B
Marketcap
$324.13
Share price
-2.34%
Change (1 day)
27.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Cost to borrow ALNY shares - Alnylam Pharmaceuticals

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.3607% (annualized)

Shares available to borrow: 1400000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2025 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Arrowhead Pharmaceuticals
ARWR
0.405%1.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
0.4081%2.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
0.3594%2.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
0.3969%3.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
3.5647%2.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
0.3594%0.85 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
0.273%1.7 M๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
0.3594%10 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel